Loading term…
Estimates of the number of patients or patient-time exposed to a medicinal product, providing context for interpreting adverse event data.
Exposure data shows: 500,000 patients treated in the period, approximately 250,000 patient-years of exposure based on average treatment duration of 6 months.
ICH E2C(R2), EU GVP Module VII
Using different exposure methodologies inconsistently, or not clearly stating assumptions and limitations.
How do you estimate patient exposure? What data sources do you use?